Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Program for Breakthrough Biomedical Research to Celebrate 15 Years

Published: Tuesday, May 21, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco.

Today, no other program in the world support scientists like the Program for Breakthrough Biomedical Research (PBBR).

A beacon for the most courageous among UCSF investigators, PBBR uses private philanthropy to fund only those ideas that challenge conventional wisdom and could never qualify for funding from increasingly conservative grant sources like the National Institutes of Health (NIH).

“This unique program dares our scientists to dig deeper, ask tougher questions, and invent novel approaches that defy the status quo,” says Keith Yamamoto, PhD, vice chancellor for research at UCSF who directs the PBBR.

The UCSF community is invited to join the scientists and supporters who have made PBBR's success possible at a special event from 3:30 to 5 p.m. in Genentech Hall on the UCSF Mission Bay campus on Thursday, May 23.

The event program, titled “Unconventional Wisdom: Advancing Scientific Discovery by Breaking the Rules,” will feature a conversation with panelists moderated by Michael Krasny, PhD, host of KQED Forum.

Panelists include:

•    Joseph DeRisi, PhD, professor, UCSF Department of Biochemistry and Biophysics Howard Hughes Medical Institute Investigator, 2004 MacArthur Fellow;
•    Susan Desmond-Hellmann, MD, MPH, UCSF Chancellor, Arthur and Toni Rembe Rock Distinguished Professor;
•    Alfred Gilman, MD, PhD, Regental Professor Emeritus, UT Southwestern Medical Center Nobel Prize in Physiology or Medicine, 1994;  and
•    Anita Sil, PhD, MD, associate professor, UCSF Department of Microbiology and Immunology Howard Hughes Medical Institute Early Career Scientist.

Supporting Innovative Basic Research at UCSF

Established by co-founders Herbert and Marion Sandler, the program formerly known as the Sandler Program in Basic Science, is currently in its 16th year. Investigators credit the program with engendering hundreds of millions of dollars in subsequent grant funding, and projects and their derivatives have resulted in hundreds of publications and dozens of patents.

Some of the notable scientists at UCSF who received this critical funding include Wendell Lim, PhD, a professor of cellular and molecular pharmacology. His lab’s PBBR grant enabled him to advance his research to the point where the NIH took notice. He has since received direct NIH funding for his efforts to engineer “smart cells” that are programmed to carry out novel therapeutic functions in cancer and regenerative medicine.

The PBBR also has opened doors for Allison Doupe, MD, PhD, whose pioneering and somewhat quirky research into songbird learning has revealed clues that may improve the understanding of human brain development and disorders such as autism, schizophrenia and Parkinson’s disease.

Doupe, a professor of psychiatry and physiology and a member of the Keck Center for Integrative Neuroscience at UCSF, has found that songbirds, like humans, have specialized areas of the brain devoted to learning. By altering the part of the brain known as the basal ganglia, Doupe and her colleagues effectively eliminated variability in the birds’ song, which in turn interfered with their ability to learn.

Since receiving her PBBR grant, Doupe has also obtained funding from the NIH, the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the Research Network on Early Experience and Brain Development.

Longtime philanthropists Herbert and Marion Sandler established the Sandler Foundation in 1991. The foundation has contributed more than $100 million to UCSF, including to PBBR; the Sandler Asthma Basic Research Center, an investigative unit dedicated to basic discovery in asthma research; support for neurosciences facilities and groundbreaking research; and a research effort focused on third world parasitic diseases.

The event on May 23 will feature a video tribute to Marion Sandler, who passed away last year at her home in San Francisco. Closing remarks will be delivered by Herbert Sandler and Chancellor Desmond-Hellmann.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
Friday, July 03, 2015
Grant Supports Creation of Patient-Derived Stem Cell Lines
Researchers have received a two-year, $600,000 grant from the National Institute on Aging to develop and study patient-derived stem cell lines.
Thursday, December 12, 2013
Prostate Cancer Stem Cells are a Moving Target
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Friday, December 06, 2013
Researchers Change Cell Types by Flipping a Single Switch
New findings have identified a method for changing one cell type into another in a process called forced transdifferentiation.
Friday, December 06, 2013
Understanding a Protein’s Role in Familial Alzheimer’s
Researchers have used genetic engineering of human iPSC’s to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease (AD).
Monday, November 18, 2013
Researchers Un-Junking Junk DNA
A study shines a new light on molecular tools our cells use to govern regulated gene expression.
Wednesday, November 13, 2013
$100M gift launches Sanford Stem Cell Clinical Center
T. Denny Sanford has committed $100 million to the creation of the Sanford Stem Cell Clinical Center at the University of California, San Diego.
Wednesday, November 06, 2013
Grafted Limb Cells Acquire Molecular ‘Fingerprint’ of New Location
Findings further creation of regenerative therapies for humans.
Wednesday, October 30, 2013
From Mature Cells to Embryonic-Like Stem Cells
Bioengineers have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage.
Tuesday, October 22, 2013
Researchers Develop Stem Cell Therapies for Acute Lung Injury
An estimated 200,000 patients a year have acute respiratory failure in the U.S. and mortality is about 30 to 40 percent.
Monday, October 21, 2013
Single Gene Mutation Linked to Neurological Disorders
Mutation could offer insights into Alzheimer’s, Parkinson’s and Huntigton’s Diseases.
Wednesday, October 16, 2013
Gene Repair Technique Could Have Many Applications
Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers have created an efficient way to target and repair defective genes.
Tuesday, August 13, 2013
Therapy Could Treat Breast Cancer that's Spread to Brain
Researchers have successfully combined cellular therapy and gene therapy in a mouse-model system to develop a viable treatment strategy for breast cancer that has spread to a patient's brain.
Tuesday, August 06, 2013
Scientists Streamline Production of Stem Cells
Researchers report a simple, easily reproducible RNA-based method of generating human induced pluripotent stem cells (iPSCs).
Friday, August 02, 2013
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!